These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29719052)
1. Effect of single-walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitro. Asai Y; Sakakibara Y; Inoue R; Inoue R; Nadai M; Katoh M Biopharm Drug Dispos; 2018 May; 39(5):275-279. PubMed ID: 29719052 [TBL] [Abstract][Full Text] [Related]
2. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
3. A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4'-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation. Easterbrook J; Fackett D; Li AP Chem Biol Interact; 2001 May; 134(3):243-9. PubMed ID: 11336973 [TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes). Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes. Kim JH; Kwon SS; Jeong HU; Lee HS Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305 [TBL] [Abstract][Full Text] [Related]
6. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841 [TBL] [Abstract][Full Text] [Related]
7. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357 [TBL] [Abstract][Full Text] [Related]
8. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs. Li J; Liu Y; Zhang JW; Wei H; Yang L Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956 [TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes. Yao HT; Chang YW; Lan SJ; Yeh TK Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511 [TBL] [Abstract][Full Text] [Related]
10. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760 [TBL] [Abstract][Full Text] [Related]
11. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. Yang J; He MM; Niu W; Wrighton SA; Li L; Liu Y; Li C Br J Clin Pharmacol; 2012 Feb; 73(2):268-84. PubMed ID: 21815912 [TBL] [Abstract][Full Text] [Related]
12. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms. Kasahara M; Suzuki H; Komiya I Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309 [TBL] [Abstract][Full Text] [Related]
13. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Niwa T; Inoue S; Shiraga T; Takagi A Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191 [TBL] [Abstract][Full Text] [Related]
14. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes. McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390 [TBL] [Abstract][Full Text] [Related]
15. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs. Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Peng Y; Wu H; Zhang X; Zhang F; Qi H; Zhong Y; Wang Y; Sang H; Wang G; Sun J Xenobiotica; 2015; 45(11):961-77. PubMed ID: 26007223 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba. Liu KH; Kim MJ; Jeon BH; Shon JH; Cha IJ; Cho KH; Lee SS; Shin JG J Clin Pharm Ther; 2006 Feb; 31(1):83-91. PubMed ID: 16476124 [TBL] [Abstract][Full Text] [Related]
18. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Niwa T; Shiraga T; Hashimoto T; Kagayama A Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907 [TBL] [Abstract][Full Text] [Related]
19. Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro. Liu KH; Kim MJ; Shon JH; Moon YS; Seol SY; Kang W; Cha IJ; Shin JG Xenobiotica; 2005 Jan; 35(1):27-38. PubMed ID: 15788366 [TBL] [Abstract][Full Text] [Related]
20. Effect of probucol on cytochrome P450 activities in human liver microsomes. Umehara K; Shimokawa Y; Miyamoto G Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]